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ABSTRACT 
EPIGENETIC REGULATION OF SLIT-ROBO PATHWAY IN 
HEPATOCELLULAR CARCINOMA  
Fatih Semerci 
MSc, in Molecular Biology and Genetics 
Supervisor: Assist. Prof Tamer Yağcı 
July, 2009 52 pages 
 
Hepatocellular carcinoma is an aggressive, chemotherapy-resistant cancer and the prognosis 
of affected patients is very poor. Therefore, unraveling molecular components of 
hepatocarcinogenesis not only leads to the improvement of diagnostic and prognostic tools 
but also may reveal novel therapeutic targets. We previously defined the differential 
expression of SLIT-ROBO genes in HCC. To explore the mechanisms of the inactivation of 
these genes, we analyzed the hypermetylation of SLIT1, SLIT2, ROBO2 and ROBO3 genes in 
a group of HCC cell lines consisting of four high-AFP expressing well-differentiated (HUH7, 
Hep3B, PLC/PRF5 and HepG2) and low-AFP expressing poorly-differentiated cell lines 
(Focus, SKHep1, Snu387 and Snu423). We first demonstrated that the transcription of all 
studied genes can be rescued upon treatment of cell lines with 5-Aza-2‟-deoxycytidine (5-
Aza-dC). Next, we analyzed the methylation of SLIT-ROBO genes by methylation specific 
PCR. All genes were found to be at least partially methylated, except ROBO3, which 
displayed a heavily methylated pattern. in silico analyses of the 5‟ upstream sequence of 
ROBO2 gene revealed a putative promoter region, an enhancer in the first intron and a CpG 
island. Methylation –specific PCR amplification of ROBO2 by using primers selected from 
this CpG island supports the potential of this region as a gene regulatory site. Therefore, it is 
worthy to extend the methylation analyses of SLIT-ROBO pathway in HCC patients. 
Furthermore, mechanistic studies on ROBO3, which was shown to counteract the 
overexpressed ROBO1 effects may shed light into the role of ROBO3/ROBO1 axis and the 
potential of ROBO3 as a tumor suppressor gene in HCC.  
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ÖZET 
SLIT-ROBO YOLAĞININ HEPATOSELLÜLER KARSĠNOMADA EPĠGENETĠK 
DÜZENLENMESĠ 
Fatih Semerci 
Moleküler Biyoloji ve Genetik Yüksek Lisansı 
Tez Yöneticisi: Yrd.Doç. Dr. Tamer Yağcı 
Temmuz 2009, 52 Sayfa 
Hepatoselüler karsinoma kemoterapiye dayanıklı, saldırgan ve kötü prognozla seyreden bir 
kanser türüdür. Bu yüzden HCC‟nin ilerlemesinde etkisi olan moleküler bileşenlerinin ortaya 
çıkarılması sadece teşhis ve takip araçlarının iyileşmesine katkıda bulunmakla kalmayıp, yeni 
tedavi hedefi olabilecek moleküllerin bulunmasına da olanak sağlayabilir. Daha önce 
grubumuz tarafından SLIT-ROBO genlerinin hepatoselüler karsinomada farklı ifade 
örüntülerine  sahip oldukları gösterildi. Bu genlerin etkisizleştirilmesinde rol alan  
mekanizmalarına ait detayları öğrenebilmek için SLIT1, SLIT3, ROBO2 ve ROBO3 genlerinin 
aşırı metillenme durumlarını 4 adet AFP ifadesi yüksek- iyi farklılaşmış (Huh7, Hep3B, 
PLC/PRF5 ve HepG2) ve 4 adet AFP ifadesi düşük- az farklılaşmış (SKHep1, FOCUS, 
Snu387 ve Snu423) karaciğer kanseri hücre hattında araştırdık. İlk olarak, araştırılan bütün 
genlerin ifadelerini 5-Aza-dC kullanılarak arttırılabileceğini gösterdik. Daha sonra, SLIT- 
ROBO  genlerinin metillenme durumlarını metilasyona özel PCR reaksiyonu ile araştırdık. 
Araştırılan bütün genlerin en azından kısmi olarak metillenmiş oldukları, buna ek olarak da 
ROBO3 geninin aşırı metillendiğini gösterdik. in-silico araştıma sonuçları ROBO2 geninin 5‟ 
ucunun yukarısında yer alan bölgelerin potansiyel bir CpG adacığı, birinci intron içerisinde 
bir yükseltici, ve bir promotör bölge içerdiğini ortaya çıkardı. Bu CpG adacığına ait primerler 
kullanılarak yapılan PCR reaksiyonları bu bölgenin bir gen düzenleyici alan olduğunu 
destekledi. Dolayısıyla, SLIT- ROBO yolağının metilasyon analizlerinin HCC hastalarında da 
araştırmak yerinde olacaktır. Bunun yanında aşırı ifade edilen ROBO1‟e zıt bir etki gösteren 
ROBO3 geniyle yapılacak mekanistik çalışmalar ROBO3/ROBO1 ekseninin rolünü 
aydınlatabilecek ve ROBO3‟ün HCC‟de bir tümör baskılayıcı gen olma potansiyeline ışık 
tutabilecektir. 
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CHAPTER 1 INTRODUCTION: 
1.1 Hepatocellular Carcinoma: 
The liver is the largest internal organ of the body. The physiological functions of liver 
can be summarized as follows: 1) Bile production and excretion 2) Excretion of bilirubin, 
cholesterol, hormones and drugs 3) Metabolism of proteins, fats and carbohydrates 4) Storage 
of glycogen, vitamins and minerals 5) Enzyme activation 6) Plasma protein (albumin and 
globulin) synthesis. 7) Blood detoxification and purification. 
Hepatocellular Carcinoma (HCC) is the most frequent primary liver cancer. It is the 
fifth most common cancer world-wide and causes approximately 600,000 deaths per year 
(Llovet JM. et al., 2003).  Hepatocarcinogenesis nearly always develops in the setting of 
chronic hepatitis or cirrhosis; conditions in which many hepatocytes are killed and 
inflammatory cells invade the liver and the connective tissue (Thorgeirsson SS and Grisham 
GW. et al., 2002). Chronic exposure to aflatoxin B1 and infection with hepatitis B virus, 
hepatitis C virus are responsible about 80% of all HCC in humans (Bosch FX. Et al., 1999). 
TGF-alpha and IGF-2 are the growth factors that are activated in response to hepatitis, 
infection with hepatitis B or C. This situation leads to increased proliferation of the cells with 
impaired G1/S checkpoint. Although this increased rate of proliferation is balanced by the 
loss of hepatocytes through apoptosis, it also results in the production of monoclonal 
populations of dysplastic hepatocytes (Thorgeirsson SS and Grisham GW. et al., 2002).  
During the preneoplastic stage, that may take 10 to 30 years to develop, additional changes 
occur like increased chromosomal abnormalities, loss of tumor suppressors, decreased 
expression of EGR1 and C/EBPα, and increased expression of FOXM1b. At later stages, 
increased expression of TGF-β is thought to be one of the main reasons of increased 
angiogenesis and metastasis (Greenbaum LE.et al., 2004). 
1.2 CpG Methylation: 
DNA methylation and other histone modifications are the key processes of the 
epigenetic regulation of the genome and they have crucial roles in the control of gene activity 
and nuclear architecture. Most widely studied epigenetic modification in humans is the CpG 
methylation. Presence of methylated cytosines in the genomic DNA is related to the 
chromosomal condensation, X inactivation, chromosome stabilization, genomic imprinting, 
and tissue specific silencing of the gene expression. This modification has a major role in the 
cell differentiation process of mammalian embryogenesis (Reik W., et al.,2001; Bacola. et 
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al.,1999) Potentially methylable CpG dinucleotides are not randomly distributed in the 
genome. They are condensed in the regions called CpG islands, which are mainly located in 
the gene regulatory sequences at 5‟ end region of the most genes (Esteller M., et al., 2007).  In 
normal cells these regions are generally unmethylated and allow the transcription of genes in 
the presence of transcription factors. Contrary to this, repetitive genomic sequences are 
heavily methylated. The latter process has an important role in the protection of the 
chromosomal integrity by preventing chromosomal instability, translocations and gene 
disruption through the reactivation of endoparasitic sequences. (Esteller M., 2005; Walsh 
C.P., et al., 1998) 
 The methylation of mammalian genomic DNA is catalyzed by DNA 
methyltransferases (DNMTs) (Figure 1.1). DNMTs can be divided into two groups: 
Maintenance and de novo DNMTs. While maintenance DNMT1 binds methyl groups to the 
hemimethylated DNA during replication, de novo DNMT3A and DNMT3B add methyl 
groups to CpG dinucleotides of unmethylated DNA (Das P.M. et al., 2004). 
 
 
 
 
 
 
 
 
 
 
Presence of m
5
CpG dinucleotides in DNA sequence directly inhibits transcription or 
recruits proteins that specifically recognize methylated DNA and initiate remodeling of 
euchromatin into heterochromatin structure. This euchromatin to heterochromatin transition 
contains the formation of the nuclease-resistant chromatin, methyl-CpG- binding proteins. 
 
 
Figure 1.1 Methylation of cytosine within CpG dinucleotides is catalyzed by DNMTs. S-
adenosylmethionine (SAM) donates methyl groups and is converted to S- 
adenosylhomocysteine (SAH). 
Maintenance (A) and de novo DNMTs (B) methylate DNA. DNMT1 binds methyl groups 
to the hemimethylated DNA during replication, whereas DNMT3A and DNMT3B can 
add methyl groups to CpG dinucleotides of unmethylated DNA. (Luczak, M. W et al., 
2006) 
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Methylated DNA recruits m
5
CpG- binding domain (MBD) proteins MeCP1 and MeCP2 that 
bind specifically to methylated DNA in whole genome and form barriers against the binding 
of the transcription factors to the promoters. MeCP1 represses heavily methylated regions 
(promoters containing more than 10 m
5
CpG dinucleotides), whereas MeCP2 can control the 
transcription of genes by binding to the single CpG dinucleotides that are symmetrically 
located in opposite DNA strands (Hendrich B, et al., 1998).  Also, DNMTs are associated 
with histone deacetlyases (HDACs), histone methyltransferases (HMTs), HP1 which are key 
regulators of histone modification.(Wade, P. A. et al., 2001; Wang. Y. et al., 2004). Moreover 
DNMT3B additionally recruits the ATP dependent chromatin remodeling enzyme hSHF2H, 
which is involved in the heterochromatin formation. (Geiman TM, et al., 2004)  
Methylation of CpG islands and then recruitment of the HDACS and other histone 
modifying enzymes is not the unique mechanism for epigenetic regulation of gene expression. 
Sometimes, histone modifications may favor or block the DNA methylation. In the fungus 
Neurospora, it has been shown that the ability to methylate histone Lys9 is required for DNA 
methylation (Jackson J. P., et al., 2002). This evidence suggests that local methylation of Lys9 
may provide a signal for the methylation of the CpG islands in the close proximity. Also in 
different pathways, histone acetylation at promoters can lead to inhibition of DNA 
methylation (Mutskov V. J., et al., 2002). 
1.2.1 Cancer and DNA Methylation: 
 Development of cancer may arise from either inherited mutations in the germ line cells 
or from changes in the DNA sequences of somatic cells during life. In turn, these sequence 
based changes either cause the activation of the protooncogenes or decrease the activity of the 
tumor suppressor genes. Additional to the sequence based mutations; epigenetic changes may 
also favor the development of cancer. Hyper/hypo-methylation of the promoter or the first 
exon of the cancer related genes is one of the common changes in the tumor cell genome. 
These epigenetic changes mimic the effect of the sequence based mutations in the tumor 
suppressor genes and protooncogenes.  
1.2.1.1 Role of Hypomethylation of in Cancer Development: 
Global hypomethylation of genomic DNA is a common feature of tumor cells and 
results in the overexpression of the protooncogenes, growth factors and genes related to 
invasion and metastasis (Szyf M, et al., 2004). For example, the expression of urokinase 
plasminogen activator (PLAU), heparanase, calcium binding protein (S100A4) and insulin-
like growth factor 2 (IGF2), all known for their  important role in the invasion and metastasis 
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of the tumors,  is induced by hypomethylation  (Senolt L. et al., 2006; Pakneshan P. et 
al.,2005 ).   
Besides the protooncogenes, hypomethylation of retrotransposons also contribute to 
the progression of cancer by destabilization of the genome. This destabilization occurs via the 
insertional mutagenesis and recombination between non-allelic repeats (Jagodzinski P. P., et 
al., 2006). Heavy methylation of CpG islands in LINEs (Long interspersed nuclear elements) 
is a host defense against retrotransposon activation (Bestor. T. H., et al. 2000). 
Hypomethylation of LINEs was observed in colon cancer and chronic lymphatic leukemia(J. 
I. Goodman., et al, 2003). 
Reasons of this global hypomethylation in malignant cell transformation are not clear. 
One hypothesis to explain this situation states that there is a complete or partial deficiency of 
numerous enzymes involved in methyl transport at the cellular level (Steele, W., C. 
Allegrucci, et al. 2005). But this hypothesis is not enough to explain the simultaneous 
hypermethylation of tumor suppressor genes promoter. Some findings suggest that 
overexpression of catalytic inactive variants of DNMT3B may shield CpG dinucleotides from 
active DNMTs (Weisenberger DJ et al., 2004). 
1.2.1.2 Role of Hypermethylation of Tumor Suppressor Genes in Cancer Development: 
 In many cancer types there has been a significant correlation between the protein 
biosynthesis of DNMT1, DNMT3B and hypermethylation of CpG islands that are located in 
the promoter regions of CDKN2A (cyclin dependent kinase inhibitor 2A), CDKN2B, CDH1 
(E-cadherin), MLH1(mismatch repair gene), RB1 (retinoblastoma 1), TIMP3 (TIMP 
metallopeptidase inhibitor 3), BRCA1, PTEN, TP53. (Table 1.1)  
Tumor Suppressor Gene Related Cancer Reference 
CDKN2A Lymphoma Herman J. G. et al., 1995. 
CDKN2B Leukemia Melki JR. et al., 1999. 
CDH1 Breast, Prostate,Colorectal Darwanto A., et al., 2003. 
Graff JR., et al., 1995. 
BRCA1 Breast, ovarian Esteller M., et al., 2000 
PTEN  Colorectal Goel A., et al., 2004 
MLH1  Colon Veigl ML., et al., 1998 
RB1 Retinoblastoma Stirzaker C., et al., 1997 
TIMP3 Colon, renal, brain Bachman KE., et al., 1999 
TP53 leukemia Agirre X., et al., 2003 
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1.3 SLIT-ROBO Family: 
 It has always been a big challenge to understand how so many neurons are connected 
to each other to form functional circuits in a precise manner. This problem has been divided 
into several distinct but interdependent developmental processes: neuronal identity 
specification, polarization of neurons, initialization of axonal and dendritic outgrowth, 
navigation of axons and dendrites towards their targets, and formation of the synaptic contacts 
(Dickson and Gilestro et al., 2004). These complex series of events constitute a major obstacle 
in understanding axonal outgrowth. However, guidance of commissural axons in both 
vertebrates and Drosophila by Slit(s) and their Robo family receptors offers us a good model 
to understand the basic steps in the axon patterning. 
1.3.1 Role of SLIT ROBO in the Guidance of Commissural Axons: 
Commissural neurons are born in the dorsal spinal cord and their axons are drawn to 
the midline by chemoattractant proteins netrin and sonic hedgehog, which emanate from the 
ventral midline. (Charron et al. 2003, Kennedy et al. 1994, Serafini et al. 1994) After crossing 
the midline, axons turn to contralateral side and continue to grow right alongside of the floor 
plate. (Figure 1.2) SLIT and ROBO family members act as repulsive cues in this process and 
prevent axons from recrossing the ventral midline.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2:  (a) Spinal cord section from E 12.5 mouse embryo (b) “Open 
book” preparation, obtained by dissecting the spinal cord along the dashed line 
indicated in A. (c) Dorsal view of two segments of the ventral nerve cord, 
showing examples of intersegmental commissural (white) and ipsilateral 
(black) neurons. A, anterior; P, posterior; D, dorsal; V, ventral; L, lateral 
(Dickson and Gilestro et al., 2004) 
a b c 
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1.3.1.1 SLITs: 
The Slit gene encodes a 190 kDa protein in the secreted form and is produced by the 
midline cells (Rothberg JM et al. 1988, 1990). Its mutant form was identified in the classic 
genetic screen for embryonic patterning (Nüsslein- Volhard et al., 1984) and commissural 
axon path finding defects (Hummel et al., 1999) in Drosophila. Further genetic (Battye R. et 
al. 1999; Kidd T. et al., 1999) and biochemical (Brose K. et al., 1999; Li HS. et al., 1999) 
studies revealed the role of Slit as the ligand of Robo. Mammals have three slit genes (Slit-1 
Slit-2, and Slit-3) which are expressed by the midline cells as their homologue in Drosophila 
(Brose K. et al., 1999; Holmes GP. et al., 1998; Itoh A. et al., 1998; Li HS. et al.,1999; Yuan 
W. et al., 1999b). Disruption of all three Slit genes in mice leads to abnormalities in the axon 
crossing through the midline or completely stalls the crossing (Long H.et al., 2004). Also the 
studies in C. Elegans showed that SLT-1 (Slit homologue in C. Elegans) is expressed at high 
levels in anterior epidermis and embryonic expression of that gene provides anterior-posterior 
guidance information to migrating neurons (Hao JC. et al., 2001). All of these works indicate 
that Slit proteins has a conserved role as a repellent guidance cues for commissural axons. 
(Figure 1.3)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
a 
d 
c b 
e 
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Slit proteins share a common domain structure which consists of a series of four 
leucine rich repeats, seven to nine epidermal growth factors (EGF) like domains, a laminin G 
domain and a C terminal cysteine-rich domain (Figure 1.3). Most of the Slits are cleaved 
within the EGF-like region by unknown proteases (Brose K. et al., 1999; Wang KH. et al., 
1999). It was proved that these proteolytic fragments of Slit protein have distinct activities in 
vitro like repelling of the olfactory bulb axons in collagen gel. This repelling also leads to 
olfactory bulb growth cones to collapse (Nguyen Ba-Charvet et al., 2001). 
1.3.1.2 ROBOs: 
Identification of Robo was based on the same type of works in the commissural axon 
guidance defected Drosophila embryos (Seeger M. et al., 1993). Too many axons have 
crossed the midline in the Robo mutant embryos (Kidd T et al. 1998a ; Seeger M. et al., 1993) 
Product of Robo gene is a cell surface protein that is expressed on the central nervous system 
axons (Kidd T. et al., 1998a). In Drosophila there are three robo genes (robo1 robo2 robo3) 
and in mammals there are four: Robo1 Robo2 Robo3 (also known as Rig-1) and Robo4 
(Known as magic roundabout). All the vertebrate Robo genes, except Robo4, seem to be 
expressed in central nervous system.  
Robo proteins have an extracellular domain comprising five immunoglobulin like and 
three fibronectin-III repeats with a single transmembrane segment and a cytoplasmic domain, 
which has no obvious catalytic activity (Kidd T. et al., 1998a). Exception to the general 
structure of Robo family is the magic roundabout that consists of two Ig domains and two 
FN3 domains. Slit binding site on the Robo proteins has been identified in the first two Ig 
domains (Liu Z. et al., 2004) that correspond to most conserved region in the Robo receptors 
(Figure 1.3).  
 The cytoplasmic domains of Robo receptors are not well conserved but they share four 
short conserved motifs. These motifs are named as CC0-3 and are thought to be sites of 
Figure 1.3: Species abbreviations used: Ag, Anopheles gambiae; Ce, Caenorhabditis 
elegans; Dm, Drosophila melanogaster; Dr, Danio rerio; Hs, Homo sapiens; Mm, Mus 
musculus. (a) Slit domain organization. Abbreviations used: aa, amino acids; LRR, leucine-
rich repeat; EGF, epidermal growth factor–like repeat; lamG, laminin G domain; Cys, 
cysteine-rich domain. arrow head indicates cleavage site in vertebrates. (b) Robo domain 
organization Ig, immunoglobulin-like domain; FN3, fibronectin type 3 domain; TM, 
transmembrane region; CC0-3, conserved cytoplasmic motifs. (c) Phylogenetic analysis of 
Slit family proteins. (d) Phylogenetic analysis of Robo family, prepared by only using the 
extracellular sequences only. (e) Alignment of selected CC motifs with consensus sequences 
and binding partners. (Dickson and Gilestro et al., 2004) 
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interaction for various cytoplasmic signaling proteins. Ena/VASP proteins are one of these 
proteins and they bind to CC1 and CC2. Also SRC Homology Domain 2 and 3 (SH2 and 
SH3), adaptor Dock/Nck proteins bind to CC2 and CC3 motifs (Fan X et al. 2003). Rho 
family GTPase activating proteins Vilse/crGAP  and srGAPS also bind to CC2 and CC3, 
respectively (Hu H. et al., 2005; Lundstorm A. et al., 2004; Wong K. et al., 2001). It is not 
clear how these signals interact with each other and repel the growth cone. Not all Robos have 
four CC domains. This in turn indicates that different Robos have different sets of 
cytoplasmic partners (Figure 1.3-e) and these different partners lead them to give different 
responses.  
 Three mammalian Robos (Robo1 Robo2 and Robo3) show a complex expression 
pattern in the neuronal populations. For example Robo1 and Robo2 levels are very low as the 
axons cross the midline and increase in crossed axons (Long H. et al.,2004). However Robo3 
shows the opposite pattern which is high before crossing and low afterwards (Sabatier C. et 
al., 2004). This expression pattern brought about the following question: What is the 
mechanism that keeps Robo1 and Robo2 levels low in commissural axons during the midline 
crossing? The answer was found in the comm. (commissureless) gene (Tear G et al., 1996) 
that has been revealed in the same mutants that had allowed the identification of robo gene. In 
the comm mutants no axons cross the midline. This data suggested that normal function of 
Comm is to antagonize the Slit-Robo function and allow the midline crossing. Comm does 
this job by functioning as an endosomal sorting receptor for Robo (Keleman K. et al., 2002). 
Comm is localized in the Golgi and in late endosomes (Figure 1.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: A model for sorting 
of Robo by Comm. (Dickson and 
Gilestro et al., 2004) 
 
9 
 
It can bind to Robo and recruit it to the endosomes. Without Comm Robo is normally 
transported down the axons but this transportation is blocked by Comm. In vertebrates, no 
homologues of Comm could be found. Instead of a vertebrate Comm, researchers found a 
surprising negative regulator of Slit-Robo signaling. This negative regulator is Robo3 (Rig-1) 
protein which was expected to function positively on the Slit signaling like other Robo‟s, but 
it did not. Robo3-/- embryos‟ commissural axons mimic the comm mutant phenotype and all 
of the commissural axons avoid the midline (Sabatier C. et al., 2004).  Expression pattern of 
Robo3 revealed its expected role. Its expression is strictly restricted along the commissural 
axons but in an opposite manner of Robo1 and Robo2. Robo3 levels are high before crossing 
and low after crossing (Sabatier C. et al., 2004) (Figure 1.5). It is obvious that Robo3 allows 
crossing of the commissural axons by inhibiting Slit- Robo1 signaling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Robo3 antagonizes Robo1 to allow crossing in mice. Model 
adapted from Sabatier et al. (2004). In pre-crossing commissural axons, 
Robo3 levels are high, and Robo1 levels low. Robo3A is thought to inhibit 
Robo1-mediated repulsion in these axons (Sabatier et al. 2004) so that they are 
instead attracted to the floor plate by netrin-1 and sonic hedgehog. After 
crossing, Robo3 levels are low, and Robo1 levels high. Axons are now 
repelled by signaling of Slit through Robo1.In addition, attraction to netrin-1 
may be downregulated, possibly owing to a Slit-dependent interaction 
between Robo1 and the netrin receptor DCC. (Dickson and Gilestro et al., 
2004) 
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1.3.2 ROBOs and SLITs Role in Other Developmental Steps: 
1.3.2.1 Kidney Bud Development: 
 Kidney development occurs along the body axis and it begins with the emerging of a 
single uteric bud from the nephric duct (Saxen L. et al., 1987). This emergence is a response 
to GNDF secretion from the adjacent nephrogenic mesenchyme (Moore M.W. et al., 1996). 
Important point in the correct positioning of the uteric bud is the restriction of GNDF 
expression to the posterior (Pachnis V. et al 1993). Anterior expansion of GNDF expression is 
correlated with supernumerary uteric bud formation (Kume T. et al., 2000). Grieshammer and 
colleagues have shown that inactivation of either Slit2 or Robo2 in mice leads to 
supernumerary bud development and that this is correlated with abnormal maintenance of 
Gndf expression in anterior nephrogenic mesenchyme (Grieshammer U. et al., 2004). Gndf 
dosage reduction in Slit2 -/- animals results in the rescue of this phenotype. (Figure 1.6)  
 
 
 
 
 
 
 
 
 
 
1.3.2.2 Endothelial Cell Migration and Angiogenesis: 
Robo4 is the most recently discovered member of the Roundabout family. It was 
identified in a data mining for endothelial specific genes (Huminiecki L.et al., 2000; 2002). 
Genes that belong to ROBO-SLIT family and expressed in the endothelial cells is not 
restricted to only ROBO4. Wu et al showed that Slit2 and Slit3 mRNAs but not Slit1 were 
expressed in the rat endothelial cells (Wu JY. et al., 2001). In 2008 Jones AC. and colleagues 
recognized the similarities between the angiogenic sprout and growing axon and found that 
Robo4 maintains the vascular integrity by inhibiting the pathologic angiogenesis and 
endothelial hyperpermeability.  Inhibition of pathologic angiogenesis is through the inhibition 
 
Figure 1.6: Uteric bud formation. 
GNDF expression is restricted to 
posterior by the act of SLIT2 
triggered ROBO2. Inactivation of 
either the SLIT2 or ROBO2 leads 
to supernumerary bud formation 
because of the increased levels of 
GNDF expression in anterior. 
(Grieshammer et al., 2004) 
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of VEGF-165 by Robo4/Slit2 axis. This inhibition also decreases the permeability levels of 
the vascular network (Jones C.A. et al., 2008).    
 
1.3.2 ROBO-SLIT Family and Cancer  
Deletion and epigenetic inactivation of Slit-Robo genes have been identified in 
different cancers. Inactivation of Robo1 results in frequent mortality. Those that survive have 
developed bronchial hyperplasia (Xian J. et al., 2001). This result showed that Robo1 is a 
tumor suppressor gene. Real time PCR analysis of seven normal prostate and 48 prostate 
tumors has shown that Robo1 expression is downregulated in the prostate cancer (Latil A. et 
al., 2003). The DUTT1/ROBO1 gene was isolated from the U2020 region (Sundaresan V. et 
al., 1998a) and this region overlaps with the common deletion site in (NCI-H2196) SCLC cell 
lines. This deletion abrogates exon 2 of the gene.  
Dallol A. and colleagues analyzed the DUTT1 gene expression in lung, breast and 
kidney tumor lines and the presence of mutations in lung, breast, kidney tumors and tumor 
cell lines. They didn‟t find any inactivating mutations but loss of expression in breast tumor 
cell lines was due to the promoter hypermethylation. 5-aza-2‟-deoxycytidine (5-Aza-dC) 
treatment rescued the expression of DUTT1 gene in this cell line. It was shown that SLIT2 is 
also epigenetically inactivated in 40% of lung and breast tumors, 72% of the primary 
colorectal cancers and 71% of the glioma cell lines. Expression is restored by 5-Aza-dC 
treatment (Dallol A. et al., 2003a; 2003b). 
 Dickinson RE and colleagues checked the expression profile of Slit 1, which is mainly 
expressed in neural tissues, and Slit3 gene, which has more widely expression pattern than 
Slit1, both in cancerous and normal tissues. After this analysis Slit3 was found to be 
methylated in 41% of breast, 33% of colorectal and 29% of glioma tumor cell lines whereas 
Slit1 was found to be methylated in 83% of glioma tumors (Dickinson RE., et al., 2004). 
 SLIT1, SLIT2 and SLIT3 expression in hepatocellular carcinoma was found to be very 
low in poorly differentiated cell lines (Ito H., et al., 2006). This finding may set a connection 
between the tumor progression and Slit Family. 
In 2003 Wang showed that Robo1-Slit2 signaling pathway is activated in the 
angiogenically active sites of the tumor. Recombinant Slit2 protein attracted the endothelial 
cells and promoted the tube formation in a Robo1 and PI kinase dependent manner. 
Neutralization of Robo1 dramatically reduced the microvessel density and also the tumor 
mass of the malignant melanoma A375 cells in vivo (Wang B. et al., 2003). 
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Slit2 treatment of the breast cancer cells was shown to inhibit the CXCL12/CXCR4 
induced breast cancer cell chemotaxis, chemoinvasion and further adhesion of the cells to the 
new environment, which are the fundamental components of the tumor metastasis (Prasad A. 
et al.,2004).  In 2008, the same group proved that Slit2 induces a tumor suppressive effect by 
coordinated regulation of B catenin and PI3K signaling pathways and by enhancing the β 
catenin/E cadherin mediated cell-cell adhesion. Also Slit2 over expressing MCF-7 cells 
showed 60-70% reduction in the tumor size compared with the mice injected with normal 
MCF-7 cells (Prasad A. et al., 2008). 
In a recent work it was proved that SLIT2 expression is downregulated in 75% of 
HCC cell lines and 83.3% of HCC samples. Decrease in the expression is significantly 
correlated with the CpG island hypermethylation. Furthermore, expression of SLIT2 was 
restored after treatment of 5-Aza-dC treatment (Jin J. et al., 2009).   
 In 2006, Ito H. and colleagues find out that ROBO1 is overexpressed in 83 of 98 cases 
of HCC (84.7%). Also they detected the ectodomain of ROBO1 in both the medium of liver 
cancer cell lines (PLC and HepG2) and sera from HCC patients. (Ito H. et al., 2006) 
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2. AIM OF THE STUDY 
Analysis of differentially expressed genes between tumor and normal tissue is one of 
the gold standards for a better understanding of carcinogenesis. Genes identified in such 
studies not only strengthen cancer research works, but also provide valuable tools for early 
diagnosis, effective monitoring of disease progression and reveal new therapeutic targets.  
Hepatocellular carcinoma (HCC) is one of the most wide-spread carcinomas 
throughout the world –responsible for 600,000 deaths annually. Diagnostic, prognostic tools 
and effective therapies for this aggressive cancer are very limited. Therefore the 
understanding of molecular pathways underlying HCC is of great importance. 
Recently, our group showed that transcripts of SLIT-ROBO family of genes (SLIT1-3, 
ROBO1-4) are differentially expressed in HCC. In the last few years, it was also shown that 
ROBO1 is overexpressed and SLIT2 is epigenetically inactivated in liver cancer. On the other 
hand, ROBO4 expression was found to be generally confined to vascular endothelium. 
Therefore, to complete the understanding of the regulation of expression of ROBO SLIT 
family genes in HCC, we decided to study whether SLIT1, SLIT3, ROBO2, and ROBO3 are 
epigenetically regulated by means of hypermethylation of their gene regulatory regions.  
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CHAPTER 3 MATERIALS AND METHODS 
 
3.1 MATERIALS 
3.1.1 Reagents 
All laboratory chemicals were analytical grade from Sigma-Aldrich (St.Louis, MO, USA), 
Farmitalia Carlo Erba (Milano, Italy) and Merck (Schucdarf, Germany) with the following 
exceptions: ethanol and methanol were from Riedel-de Haën (Germany). Agar, tryptone and 
yeast extract were obtained from Gibco (Carlsbad, CA, USA), BRL Life Technology Inc. 
(Gaithersburgs, MD, USA). 
3.1.2 Bacterial Strains 
The bacterial strain used in this work was E.coli DH5α. 
3.1.3 Enzymes 
Restriction endonucleases used for gene cloning were purchased from Jena Bioscience 
(Germany). T4 DNA ligase was purchased from Fermentas GmbH (Germany). DyNAzyme II 
and Phusion DNA Polymerase was purchased from Finnzymes (Espoo, Finland).  
3.1.4 DNA Markers 
DNA molecular weight standards were purchased from Fermentas GmbH (Germany) (100 bp-
SM0241, 1kb-SM0311) and Jena Bioscience (Germany) (low range DNA ladder 50-1000 bp, 
high range DNA ladder 0.5-10kb).  
3.1.5 Oligonucleotides 
The oligonucleotides used in polymerase chain reactions were synthesized and supplied from 
Iontek Inc. (Istanbul, Turkey) and Alpha DNA (Germany). 
3.1.6 Plasmids 
pGL3 Luciferase Reporter Vector was purchased from PROMEGA Corporation (USA). e1b  
TATA box added modified version of  pGL3 was kindly provided by Hani Alotaibi.  
3.1.7 Electrophoresis, photography and spectrophotometer 
Electrophoresis grade agarose was obtained from Sigma Biosciences Chemical Company Ltd. 
(St. Louis, MO, USA). Horizontal electrophoresis apparatuses were from E-C Apparatus 
Corporation (Florida, USA). The power supply Power-PAC300 and Power-PAC200 was from 
Bio Rad Laboratories (CA, USA). The Molecular Analyst software used in agarose gel profile 
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visualizing was from Vilber Lourmat (France). Beckman Spectrophotometer Du640 was 
purchased from Beckman Instruments Inc. (CA. USA) and Nanodrop ND-1000 Full-spectrum 
UV/Vis Spectrophotometer was purchased from Thermo Fisher Scientific (Wilmington, DE, 
USA). The Reporter Microplate Luminometer Reader was from Turner BioSystems Inc 
(Sunnyvale, CA, USA). 
3.1.8 Tissue culture reagents and cell lines 
Dulbecco‟s modified Eagle‟s medium (DMEM), RPMI 1640, trypsin, non-essential amino 
acids, penicillin/streptomycin mixture and fetal calf serum were obtained from HyClone 
(South Logan, UT, USA). Tissue culture flasks, petri dishes and cryotubes were purchased 
from Costar Corp. (Cambridge, England). Geneticin-G418 sulfate was purchased from 
GibcoBRL (Carlsbad, CA, USA). 
3.1.9 Transfection reagents 
FuGene HD (Roche, Mannheim, Germany) and Licofectamine 2000 (Invitrogen, Carlsbad, 
CA, USA) transfection reagents were used in this study. OptiMEM I serum free medium was 
purchased from Invitrogen (Carlsbad, CA, USA). 
3.1.10 Kits 
RNeasy Mini Kit was obtained from Qiagen (Hilden, Germany). NucleoSpin RNA II Kit was 
obtained from Macherey-Nagel (Duren, Germany). DyNAmo cDNA Synthesis Kit and 
DyNAmo™ HS SYBR® Green qPCR Kit were purchased from Finnzymes (Espoo, Finland). 
Qiaprep spin mini-prep kit (for small scale DNA isolation), Qiafilter plasmid midi kit (for 
medium-scale DNA isolation), Qiaquick PCR purification and gel extraction kits (for 
recovery and extraction of DNA from agarose gel) were from Qiagen (Hilden, Germany). 
UltraClean Tissue DNA Isolation Kit was purchased from MOBIO Laboratories (Carlsbad, 
CA, USA). Bisulfite treatment kit was obtained from EPIGENTEK MethylAMP® DNA 
modification kit (NY, USA) 
3.2 SOLUTIONS AND MEDIA 
3.2.1 General solutions 
Tris-acetic acid-EDTA (TAE): Stock solution (50XTAE) was prepared by addition of 121g 
Tris-base, 18.6g EDTA, and 28.55ml glacial acetic acid to 500ml ddH2O. pH of the stock 
solution was adjusted to 8.5. Working solution (1XTAE) was prepared by dilution of 
50XTAE to 1X with ddH2O. 
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Ethidium bromide: 10mg/ml in water (stock solution), 30ng/ml (working solution). 
6X Agarose gel loading dye: A mixture of 0.009g bromophenol blue (BFB), 0.009g xylene 
cyanol (XC), 2.8ml ddH2O, 1.2ml 0.5M EDTA was prepared. The total volume was brought 
to 15ml by addition of glycerol. 
3.2.2 RNA solutions 
DEPC-treated water: 1ml DEPC was added to 1L ddH2O and stirred under hood overnight. 
DEPC was inactivated by autoclaving. 
3.2.3 Microbiological media, reagents and antibiotics 
Luria Bertani (LB) medium: Per liter; 10g bacto-tryptone, 5g bacto-yeast extract, 10g NaCl. 
For LB agar plates, 15g/L bacto agar was added. 
Glycerol stock solution: A final concentration of 25% glycerol in LB was added to bacterial 
culture. 
Ampicillin: 100mg/ml solution in ddH2O, sterilized by filtration and stored at -20°C (stock 
solution). Working solution was 100μg/ml.  
SOB medium: Per liter; 20g tryptone (2%), 5g yeast extract (0.5%), 0.584g NaCl (10mM), 
0.1864g KCl (2.5mM) autoclaved to sterilize. Then, 2.46g MgSO4 and 2.03g MgCl2 (10mM) 
are added. 
SOC medium: SOB + 20mM glucose from filter sterilized 1M glucose stock solution in 
ddH2O. 
Transformation buffer (TB): 10mM PIPES, 55mM MnCl2, 15mM CaCl2, 250mM KCl. Filter 
sterilized and stored at 4
o
C. 
3.2.4 Tissue culture solutions 
DMEM/RPMI1640 growth media: 10% FBS, 1% penicillin/streptomycin, 1% non-essential 
amino acid were added and stored at 4
o
C. 
Freezing solution: 10% DMSO and 90% FCS were mixed freshly. 
Phosphate buffered saline (PBS): Stock solution (10XPBS) was prepared by dissolving 80g 
NaCl, 2g KCl, 17.8g Na2HPO4.2H2O, and 2.4g KH2PO4 in 1L ddH2O. Working solution 
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(1XPBS) was prepared by dilution of 10XPBS to 1X with ddH2O. pH of the working solution 
was adjusted to 7.4. 
3.3 METHODS 
3.3.1 General methods 
3.3.1.1 Bacterial transformation 
3.3.1.1.1 Super-competent E.coli preparation 
Super-competent E.coli preparation was described by Inoue (Inoue H. et al., 1990). E.coli 
DH5α cells were grown in SOB medium at 30oC to an O.D.600 of 0.5-0.6 with vigorous 
shaking at 225rpm and cooled down on ice for 10 minutes. Cells were transferred to 500ml 
centrifuge bottles and centrifuged at 2500g for 10 minutes (Beckman JA10 rotor, pre-cooled 
to 4
o
C). The pellet was resuspended in ice-cold transformation buffer (1/3 of initial culture 
volume) by gently swirling and kept on ice for 10 minutes. The suspension was then 
centrifuged at 2500g for 10 minutes. The pellet was gently re-suspended in ice-cold 
transformation buffer (1/12.5 of initial culture volume) then DMSO was added with gently 
swirling to a final concentration of 7% and incubated on ice for 10 minutes. Super-competent 
cells were aliquotted to 1.5ml eppendorf tubes, then immersed in liquid nitrogen to snap-
freeze and stored at -80
o
C.  
3.3.1.1.2 Super-competent E.coli transformation 
Super-competent cells were thawed on ice for ~15minutes. From this, 150µl of cells were 
pipetted to pre-chilled transformation tubes and immediately mixed with the ligation products 
or 10ng intact plasmid.  Then the complex was incubated on ice for 30 minutes, after which a 
heat-shock at 42
o
C for 30-45 seconds applied. Heat-shocked cells were immediately replaced 
on ice for 2 minutes and consequently 850µl LB medium was added. For antibiotic resistance 
gene to be expressed, the cells were rotated at 225rpm for 1hour in a 37
o
C shaker. If ligation 
product was used then the cells were pelleted and re-suspended in 100µl LB; otherwise when 
intact plasmid was used, 100µl from 1ml total culture was taken and spread on agar plates 
with suitable selection antibiotic. Under aseptic conditions, plates were left to drain for 
~10minutes and then placed in an inverted position into 37
o
C incubators for overnight (12-16 
hours). Next day the emerging colonies were collected for mini-prep.        
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3.3.1.2 Long term storage of bacterial strains 
To keep bacterial cells including plasmid in it or as empty for future experiments and to have 
a stock of strain in a laboratory is necessary. The most frequently used method is “Glycerol-
Stock” method. A single colony picked from either an agar plate or a loop-full of bacterial 
stock was inoculated into 5ml LB (with a selective agent if necessary) in 15ml screw capped 
tubes. Tubes were incubated overnight at 37
oC and at 225rpm. For glycerol stock, 500μl of 
saturated culture was added into 700ul of 50% glycerol v/v. This mix was frozen/stored at -
80
o
C. 
3.3.1.3 Plasmid DNA preparation 
Small scale isolation of plasmid DNA was performed with Qiaquick spin mini-prep kit 
according to the manufacturer‟s instructions. This procedure yields approximately 200ng/μl of 
plasmid DNA for 1ml of LB culture. For large-scale preparation of pure plasmid DNA, the 
Qiafilter plasmid midi kit was used by following the manufacturer‟s instructions. This 
procedure yields approximately 1μg/μl of plasmid DNA for 100 ml of LB culture. 
3.3.1.4 Preparation of genomic DNA from cultured cells 
Cultured cells were grown in 100mm tissue culture dishes to 70-80% confluency, trypsinized, 
and washed with 1XPBS. Genomic DNA was isolated by using UltraClean Tissue DNA 
Isolation Kit (MOBIO Laboratories, Carlsbad, CA, USA) following manufacturer‟s 
instructions. 
3.3.1.5 Extraction of total RNA from tissue culture cells 
Exponentially growing monolayer cultures were washed twice with ice-cold PBS, scraped 
with a scraper, pelleted at +4
o
C and stored at -80
o
C until needed for RNA preparation. The 
total RNA isolation from cell line pellets was performed directly by use of NucleoSpin RNA 
II kit according to the manufacturer‟s instructions. The RNAs were eluted in a total volume of 
40μl. The concentration of the isolated RNA and O.D.260/280 ratio were measured with the 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Montchanin, DE, USA). 
Isolated RNAs were snap-frozen with liquid nitrogen and stored at -80
o
C. 
3.3.1.6 Quantification and qualification of nucleic acids and proteins 
Concentration and purity of the double stranded nucleic acids (plasmid and genomic DNAs) 
and total RNAs were determined by using the RNA and double-stranded(ds) DNA methods 
on Nanodrop ND-1000 Full-spectrum UV/Vis Spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA). Concentration and purity of proteins were determined by using the 
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Beckman Instruments Du Series 600 Spectrophotometer software programs on the Beckman 
Spectrophotometer Du640 (Beckman Instruments Inc. CA. USA). 
3.3.1.7 Restriction enzyme digestion of DNA 
Restriction enzyme digestions were routinely performed in 20μl or 50μl reaction volumes and 
typically 5-10μg DNA was used. Reactions were carried out with the appropriate reaction 
buffer and conditions according to the manufacturer‟s recommendations. Digestion of DNA 
with two different restriction enzymes was also performed in the appropriate common 
reaction buffer and conditions recommended by the manufacturer. 
3.3.1.8 Agarose gel electrophoresis of DNA 
DNA fragments were fractionated by horizontal gel electrophoresis in 1-2% (w/v) agarose gel 
by using 1XTAE buffer. DNA fragments less than 1 kb were generally separated on 1.0% or 
2.0 % agarose gel, those greater than 1 kb (up to 11 kb) were separated on 1 % agarose gels. 
Agarose was completely dissolved in 1XTAE electrophoresis buffer in the desired 
percentages and ethidium bromide solution was added to final concentration of 30ng/ml. 
6XDNA loading dye was added to 10μl of quantitative real time RT-PCR (QRT-PCR) 
products and 20μl of normal PCR products such that the final dye concentration will be 1X, 
and total volume was loaded to each well. Nucleic acids were visualized under ultraviolet 
light (long wave, 340nm) and GeneRuler (Fermentas) DNA size markers was used to estimate 
the fragment sizes.1 kb DNA ladder was loaded for products sizes of over 1kb and 100 bp 
ladder for product sizes of below 1kb. 
3.3.2 Tissue culture techniques 
3.3.2.1 Cell lines 
13 hepatoma (Huh7, FOCUS, Mahlavu, Hep40, Hep3B, PLC/PRF/5, SK-Hep1, Snu182, 
Snu387, Snu398, Snu423, Snu449 and Snu475) and 1 hepatoblastoma (HepG2) cell lines 
were used in this study and cultured as previously described (Cagatay T. and Ozturk M., 
2002) 
3.3.2.2 Thawing cryopreserved cells 
One vial of the frozen cells from the liquid nitrogen tank was taken and immediately put into 
ice. The vial was left 1 minute on the bench to allow excess nitrogen to evaporate and then 
placed into 37
o
C water bath until the external part of the cell solution was thawed (takes 
approximately 1-2 minutes). The cells were directly poured into a 15ml sterile tube containing 
20 
 
10ml cold fresh medium. The cells were centrifuged at 1500rpm at 4
o
C for 5 minutes. 
Supernatant was discarded and the pellet was resuspended in 10ml 37
o
C culture medium to be 
plated into 100mm dish. After overnight incubation in a humidified incubator at 37°C 
supplied with 5% CO2, culture mediums were refreshed. 
3.3.2.3 Growth conditions of cell lines 
Focus, Hep40, Hep3B, Hep3B-TR, HepG2, HUH7, Mahlavu, PLC/PRF/5, SK Hep1 cells 
were cultured in low-glucose DMEM supplemented with 10% FBS, 100U/ml Penicillin-
Streptomycin, and 0.1mM non-essential amino acids (HyClone, Utah, USA). SNU387, 
SNU398, SNU423, SNU449, SNU475 cells were cultured in RPMI1640 medium 
supplemented with 10% FBS, 100 U/ml Penicillin-Streptomycin, 0.1mM non-essential amino 
acids (HyClone, Utah, USA). The growth medium was aspirated and the cells were washed 
once with 1XPBS. Trypsin was added to the flask to remove the monolayer cells from the 
surface. The fresh medium was added and the suspension was pipetted gently to disperse the 
cells. The cells were transferred to either fresh petri dishes or fresh flasks using different 
dilutions (from 1:2 to 1:10) depending on requirements. All media and solutions used for 
culture were kept at 4°C (except stock solutions) and warmed to 37°C before use. 
3.3.2.4 Cryopreservation of cell lines 
Exponentially growing cells were harvested by trypsinization and neutralized with growth 
medium. The cells were counted and precipitated at 1500rpm for 5min. The pellet was 
suspended in a freezing solution (10%DMSO, 20%FCS and 70%DMEM for adherent cells) at 
a concentration of ~4x10
6
cells/ml. 1ml of this solution was placed into 1ml screw capped 
cryotubes. The tubes were first frozen at -20
o
C for 0.5-1hours and then left at -80°C 
overnight. The next day, the tubes were transferred into the liquid nitrogen storage tank. 
3.3.2.5 Transient Transfection of Cell Lines: 
3.3.2.5.1  Transient Transfection of Eukaryotic Cells Using  with “Lipofectamine Reagent” 
Transfection was performed with Lipofectamin 2000 reagent (Invitrogen) following 
manufacturer‟s instructions. 
3.3.2.5.2 Transient Transfection of Eukaryotic Cells Using with FuGene HD: 
Transfection was performed with FuGene HD reagent (Invitrogen) following manufacturer‟s 
instructions. 
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3.3.2.6  5-Aza-dC Treatment of the Cells 
5-Aza-dC stock solutions was prepared with the concentration of 100uM in DMEM. Cells 
were treated with 2.5 uM of 5-Aza-dC for 4 days.  
3.3.3 cDNA synthesis 
cDNA was synthesized by using DyNAmo
TM
 cDNA Synthesis Kit (Finnzymes, Espoo, 
Finland) according to manufacturer‟s instructions. Briefly; for 1X reaction 1μg of total RNA, 
1μl oligo(dT) primers or 1 μl random hexamers and required amount of ddH2O were mixed in 
a total 8μl volume, then incubated at 65°C for 5min and chilled on ice. Then, 4 μl of 5X First 
Strand Buffer, 1 μl of RNase inhibitor and 2 μl of deoxynucleotide triphosphate mix (10 mM) 
were added and the reaction was incubated at 37°C for 5 min. Finally, the mixture was 
incubated at 42oC for 1 hr with 1 μl of reverse transciptase enzyme. The reaction was stopped 
by heating the mixture for 10 min at 70oC. Each cDNA sample was diluted at a ratio of 1:5 
with ddH2O and stored at -20oC to be used as a PCR template for further experiments. The 
oligo(dT) primed cDNA samples were used for the analysis of all the target and reference 
genes included in this study.  
 
3.3.4 Primer design for Cloning and MS-PCR 
The primer pairs that have been used in cloning were as follows: Forward primers F1, F2, F3, 
F4 for putative promoter region were selected from the beginning part of the CpG island, 
beginning of the promoter, end of the promoter and end of the CpG island respectively. 
Primers used for amplifying the ROBO2 CpG island by MS-PCR was designed by 
MethPrimer website. Other MS-PCR primers were previously described (Nguyen et al., 
2006). All Primers were listed in Table 3.1. 
TABLE 3.1 LIST OF PRIMERS 
# Primer Name: Sequence: 
1 F1 e1b TGCACACGCGTCCTTCCTCCTACTCGGCTTC 
2 F2 e1b TGCACACGCGTGCAGACGGAGGGATGAATAA 
3 F3 e1b TGCACACGCGTCGCCTTCCCTCCTAGAAGTC 
4 F4 e1b TGCACACGCGTCTTTTGGAAACCGGAGAGGT 
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5 Reverse (-F4) e1b TGCACCTCGAGCTCCTTTGCAGCGGTGTT 
6 Reverse (full length) e1b  TGCACCTCGAGTTTGACATATTAAAAAGGATCCAG 
7 Enhancer Wide Forward CCATTGGAGAAAACCTCAAAA 
8 Enhancer Wide Reverse GGTGGCATTGTAGCTGTCCT 
9 Enhancer true F TGCACGGATCCCATGGGAATATTGAGTCCTTATCA 
10 Enhancer true R TGCACGTCGACCCTTCCTCTTGGCAAGTCTG 
11 R2 PRO-R GCAGACCCATGGTGACATATTAAAAAGGATCCAG 
12 R2 PRO-F1 TGCAC AAGCTT CCTTCCTCCTACTCGGCTTC 
13 R2 PRO-F2 CGCAC AAGCTT GCAGACGGAGGGATGAATAA 
14 R2 PRO-F3 TGCAC AAGCTT CGCCTTCCCTCCTAGAAGTC 
15 R2 PRO-F4 TGCAC AAGCTT CTTTTGGAAACCGGAGAGGT 
16 R2 PRO-R5 GTCCACCATGGCTCCTTTGCAGCGGTGTT 
17 R2PW-F CCACACCCAGAGCCT 
18 R2PW-R AGGCTCTTGCAGGAGATTGA 
19 SLIT1-UR2   ttttcctcctcAcaAcaAtcaA 
20 SLIT1-UF2  TgggTttgTgTgTggTgTTT 
21 SLIT1-MR2  aAAcgccgtcgcttAAaAA 
22 SLIT1-MF2  TtcgTtcgcgagTTagacg 
23 SLIT3-MF ggtttcgtcgatggagttgt 
24 SLIT3-MR aaacgcgtaaaacccgaaa 
25 SLIT3-UF TGTGggTTagTGgggTTagg 
26 SLIT3-UR cacaaacaaaacaaaacactcca 
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27 ROBO1-MF2 cggcggcgatagTagTTaaa 
28 ROBO1-MR2 cgAAActAAAAAcgcccaAa 
29 ROBO1-MF3 cggcgtgcgTTTTTaTaatg 
30 ROBO1-MR3 gccAcgAAtAAcccgctAct 
31 ROBO1-UF TggTggTaaagttggggtgt 
32 ROBO1-UR ccAaAcccttcctccAAaAc 
33 ROBO3-MF gcgggaTtTtTagTcggTTT 
34 ROBO3-MR gAcctctccgcaAActAAcg 
35 ROBO3-UF TggTgggaTtTtTagTTggTTT 
36 ROBO3-UR ccAcaActtccccAcAAcAc 
37 ROBO2-MF TATTATTTTTAGAGGCGGTATCGC 
38 ROBO2-MR AATAAAAAATCCGAACTCCTACGTA 
39 ROBO2-UF ATTATTTTTAGAGGTGGTATTGTGG 
40 ROBO2-UR AATAAAAAATCCAAACTCCTACATA 
41 SLIT1 F GACGTGGTCTGTCCCCACAA 
42 SLIT1 R AATCTCATTGTTATTCAATCGCAGTT 
43 SLIT3 F CCGCCTAACTACACAGGTGAGCTAT 
44 SLIT3 R CGCTGTAGCCAGGGACACACT 
45 ROBO2 F GGGTTACTACATCTGCCAGGCTT 
46 ROBO2 R AGGTGGAGGTCTATCTGTCAAAACAT 
47 ROBO3 F CAGTGTCCGATGGAAGAAGG 
48 ROBO3 R GTCCATCTCCTGCACATTGG 
24 
 
49 GAPDH F GGCTGAGAACGGGAAGCTTGTCAT 
50 GAPDH R CAGCCTTCTCCATGGTGGTGAAGA 
51 GL2 GGAAGACGCCAAAAACATAAAG 
52 RV3 CTAGCAAAATAGGCTGTCCC 
53 RV4 CGCGGGGCATGACTATCGTC 
 
TABLE 3.2 PRIMER EFFICIENCIES & PRODUCT SIZES FOR REAL TIME PCR 
PRIMERS: 
PRIMER EFFICIENCY PRODUCT SIZE 
Robo2 1.9 98 
Robo3 1.9 106 
Slit1 1.9 130 
Slit3 2.0 136 
Gapdh 2.0 143 
3.3.5 Fidelity and DNA contamination control in first strand cDNAs 
The fidelity and genomic DNA contamination of first strand cDNAs were checked before 
performing expression analyses. 2μl of diluted first strand cDNA was used for cold-PCR 
amplification of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript. 
GAPDH primer pair for this analysis was designed to produce a 151 bp fragment from cDNA 
and 250 bp fragment from genomic DNA. 
3.3.6 Methylation Specific PCR 
Bisulfite treated DNA of HCC cell lines were eluted in 8µl of elution buffer. PCR volume is 
50 µl. Briefly, reaction content is: 1µl of DynAzyme II, 5 µl of dNTP (2mM), 4 µl of bisulfite 
treated DNA, 1.5 µl of Mg2+, 5 µl of PCR Buffer (10X) and 33.5 ul of ddH2O. Reaction 
conditions are as follows: 95
o
C 15 min, (94
o
C 30 sec, 58
o
C 30 sec, 72
o
C 40 sec) 45 cycles, 
and final extension at 72
o
C for 10 min. 
3.3.7 Cloning Strategies for ROBO2 Putative Promoter and Enhancer: 
During the cloning works Phusion® DNA Polymerase FINNZYMES were used because of its 
high proof reading activity, low mutation rate and increased specificity. To synthesize the 
fragments of putative promoter region, nested PCR primers (R2PW-F& R2PW-R) were used 
and extended fragments were obtained. Then, these fragments were used as DNA source of 
the next PCR. Reverse primer (R2-PRO-R) contains 3 mispriming bases which are not 
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complementary to the genomic DNA. Mispriming bases at the 3‟ end of the R2-PRO-R gene 
was designed to fit into translation start site of luc gene, NcoI restriction site, the end of the 5‟ 
UTR of ROBO2 gene just before the translation start site. These first constructs contain NcoI 
and HindIII restriction sites. Putative enhancer region was also amplified from the nested 
PCR product. Then enhancer region insert with SalI and BamHI restriction sites. Inserts for 
e1b pGL3 vector contains MluI and XhoI restriction sites and synthesized from the nested 
PCR product made with R2PW-F& R2PW-R. Exclusion of F4 region from these constructs 
were made by using the same forward primes of F1,2,3,4 synthesis both for pGL3 basic and 
e1b but the reverse primers were different. “Reverse (-F4) e1b” & “R2 PRO-R5” primers 
were used. PCR reactions were performed in 50 µl: 10 µl of Phusion GC- Buffer, 0.6 µl of 
Phusion DNA Polymerase, 5 µl dNTP, 2 µl of genomic DNA (or nested PCR product), and 
32.4 µl ddH2O with 98
o
C 3 min, (98
o
C for 10 sec, 60
o
C for 15 sec, 72
o
C for 45 sec)45 cycles, 
72
o
C for 10 min for final extension. All inserts cut and isolated from the gel. Then, they 
exposed to restriction enzymes for 4 hours. 1µg of DNA were cut for each insert in 50µl 
volume which contains 5 µl of restriction enzyme buffer, 1 µl of enzymes. Restriction 
products were purified with Qiagen PCR Purification Kit. Ligations of the inserts to vectors 
were performed with T4 DNA ligase in 10 µl volume which contains 100 µg vector and 
required amount of DNA, 1 µl of ligation buffer, 1 µl of T4 DNA ligase and ddH2O.  
Required insert amount was calculated with the following formula: ng of insert = [(ng of 
vector X kb size of insert) / kb size of vector] X molar ratio of insert/ vector (which is 1/3). 
3.4 Quantitative real time RT-PCR 
Real-time qRT-PCR was performed on BioRad iCycler (Bio-Rad, California, USA) using the 
BioRad iQTM SYBR Green Supermix. The amplification mixtures contained 1.0 μl of 1:5-
diluted cDNA template, 6.25 μl SYBR Green PCR Master Mix Buffer (2X), and 10 pmol of 
forward and reverse primers in a total volume of 12.5 μl. The cycling conditions were as 
follows: an initial incubation of 95°C for 5 min and then 45 cycles of 95°C for 30 s and 60°C 
for 30 s during which the fluorescence data were collected. To verify that the used primer pair 
produced only a single product, a dissociation protocol was added after thermocycling, 
determining dissociation of the PCR products from 55°C to 95°C in 80 cycles. 12.5μl mineral 
oil was added to cover top of the mixture to prevent evaporation. The amplification reactions 
were performed in 96 well-PCR plates and the plates were sealed with optical sealing tapes 
(Bio-Rad, California, USA). All PCR reactions were studied in duplicate. Treated and 
untreated samples were always analyzed in the same run to exclude between-run variations 
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and each sample was studied in duplicate. A no-template control of nuclease-free water was 
included in each run. Following amplification, a reaction product melt curve was obtained to 
provide evidence for a single reaction product. The iCycler iQ Optical System Software 
(version 3, BioRad Laboratories) was used to determine the melting temperatures of the 
products. The threshold cycle (Ct) value was calculated as the cycle where the fluorescence of 
the sample exceeded a threshold level.  
In cell lines and tissues, the relative expression ratio (R) of SLIT-ROBO in 5-Aza dC  
treated and non treated cells were measured based on a modified ∆∆Ct formula (35) and 
normalized to GAPDH or ACTB (reference gene). In R= (Etarget) 
∆Ct 
target
 (control-sample)
 / (Eref) 
∆Ct 
ref
 (control-sample)
 formula Etarget and Eref  reflect PCR efficiencies of the primers for target genes 
and reference genes, respectively. PCR efficiency values for each primer pair was obtained by 
constructing a standard curve using threshold cycle (Ct) values derived from 6 data points, 
corresponding to 2-fold decrements of an original cDNA stock (duplicates were prepared for 
each dilution). The slope of the resulting curve was used to calculate the E value of primer 
pairs according to E = 2
-1/slope
 formula. PCR efficiencies of the genes ranged between 1.9 and 
2.0. ∆Ct was the difference between the Ct values of controls and samples. 
3.5 Computer Analysis: 
The sequences of the cloned FAM134B isoforms and of their mouse homologues were 
obtained from NCBI (National Center for Biotechnology Information) and UCSC (University 
of California, Santa Cruz) Genome Browser. The exon-intron information of these genes was 
derived using Ensembl Genome Browser at http://www.ensembl.org. Restriction endonuclease 
maps of the plasmid DNAs were analyzed by using the Clone.exe program. Primers were 
designed by using Primer.exe program provided by Whitehead Institute for Biomedical 
Research. The results of the DNA sequencing of engineered constructs were visualized using 
Finch TV 1.4 available for download at http://www.geospiza.com/finchtv.html. The 
alignments of nucleic acids was performed by using the NCBI Blast2Sequences algorithm 
available at the web page http://www.ncbi.nlm.nih.gov/BLAST/ , BIOEDIT Sequence 
Alignment Editor software publicly available at 
http://www.mbio.ncsu.edu/BioEdit/BioEdit.html and ClustalW algorithm provided by EMBL-
EBI at http://www.ebi.ac.uk/Tools/clustalw2/index.html.  
Another database used in this study is OncoDB.HCC- Oncogenomic Databas of 
Hepatocellular Carcinoma (Jou et al., 2007) For querying name of ROBO-SLIT family 
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member genes were typed in the „Gene description‟ section of „Display queried gene and 
reginal data‟ query tool and „region around gene option‟ on the left side of the query tool was 
left as default, +/- 10 Mb (megabases). On the return page, clicking on „display region‟ gives 
information on the mapped human markers and LOH (loss of heterozygosity) regions around 
the queried gene. 
For enhancer and promoter analysis GENOMATIX,CORG and PromoterScan 
softwares were used. The search algoritm was set to default in all parameters. Results of the 
putative promoter and enhancer sequences were listed according to their Z-score with the 
possible transcription factors. 
For CpG island prediction analysis, EMBOSS CpG Plot software was used. All the 
parameters were set to default.  
3.6 Sequencing of Constructs: 
We have F1-pGL3, F2-pGL3, F3-pGL3, F4-pGL3 constructs sequenced in Iontek Inc 
(Istanbul, Turkey) by providing the company with PCR products and primers. Representative 
F1-pGL3 sequencing results were at the appendices part. To sequence F1, F2, F3 constructs 
F4, GL, and RV primers were used. For F4 construct GL and RV primers were used. For 
sequencing primers see the table 3.1 
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CHAPTER 4 RESULTS 
4.1 Identification of ROBO-SLIT Family Genes Methylation Status and Expression 
Patterns: 
4.1.1 Mutation Database Scanning of ROBO-SLIT Family: 
Our group recently showed that members of ROBO-SLIT family of genes have 
different expression pattern in hepatocellular carcinoma cell lines (Avci ME et al. 2008). This 
differential expression might be due to either genetic mutations, and/or the change in the 
epigenetic control mechanisms of these genes. To check the first possibility the Human 
Genetic Mutation Database was scanned for the Small/ Gross Deletions, Small/ Gross 
Insertions type mutations for ROBO1, ROBO2, ROBO3, ROBO4, SLIT1, SLIT2, and SLIT3 
genes. No results were found for these types of mutations in Hepatocellular Carcinoma. Also 
OncoDB.HCC Database was scanned for the same mutation types and no such abnormalities 
could be found. Therefore, we turned out to study the methylation of SLIT-ROBO genes. As 
mentioned in the introduction part, SLIT ROBO family members were shown to be regulated 
by hypermethylation in different cancer types but, except SLIT2, this is never tested in HCC. 
Also, there is only one study that described ROBO2 methylation in head and neck squamous 
carcinoma. On the other hand, ROBO1 is upregulated in liver cancer and ROBO4 expression 
was repeatedly shown to be confined to vascular endothelium. Hence, the focus of this study 
is to explore the epigenetic regulation of ROBO2, ROBO3, SLIT1 and SLIT3 in HCC. 
4.1.2 Identification of ROBO2 Gene Regulatory Sequences: 
Although ROBO2 gene has very important roles in the development of kidney, and guidance 
of commissural axons, its promoter and enhancer sequences were not identified.  Minus 10kb 
of Robo2 gene translation start site (TSS) sequence were retrieved from ENSEMBL Genome 
Browser Database. This sequence was scanned for the presence of both putative promoter and 
CpG Island presence. CpG Island Analysis was performed by Emboss CpG Plot website 
(Figure 4.1). A CpG Island was found to be located in the -1482 to -621 bp relative to TSS 
(Figure 4.2). Promoter Analysis was performed by “Promoter Scan” software developed by 
Bioinformatics and Molecular Analysis Section of NIH. Putative promoter region was found 
to be located in the -1343 to 1043 bp relative to TSS (Figure 4.3). This region have 
29 
 
strong promoter prediction score and high number of possible transcription factor binding 
sites (Figure 4.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1  
CpG Prediction Plot of 
Robo2 Gene. CpG 
Island was found to be 
located in the -1482 to -
621 bp relative to TSS 
Significant Signals: 
 Name                   TFD #  Strand  Location  Weight 
TTR_inverted_repeat  S01112 - 263 3.442000 
AP-2                 S01936 + 291 1.108000 
JCV_repeated_sequenc S01193 - 298 1.658000 
Sp1                  S00781 + 301 3.191000 
Sp1                  S00801 - 306 3.119000 
T-Ag                 S00974 + 323 1.086000 
AP-2                 S01936 - 326 1.091000 
GCF                  S01964 - 329 2.284000 
UCE.2                S00437 - 364 1.216000 
GCF                  S01964 + 376 2.361000 
NF-kB                S01498 + 378 1.080000 
APRT-mouse_US        S00216 - 382 7.604000 
AP-2                 S00346 + 405 1.355000 
AP-2                 S01936 + 406 1.108000 
AP-2                 S01936 - 415 1.091000 
JCV_repeated_sequenc S01193 - 441 1.658000 
Sp1                  S00978 + 453 3.013000 
Sp1                  S00781 + 454 3.191000 
Sp1                  S00802 - 458 3.061000 
Sp1                  S00801 - 459 3.119000 
UCE.2                S00437 + 461 1.278000 
GCF                  S01964 + 487 2.361000 
AP-2                 S00346 + 499 1.355000 
EGR-1                S01956 + 500 5.736000 
KROX24               S01624 + 500 9.559000 
AP-2                 S01936 + 502 1.108000 
Sp1                  S00956 + 502 9.386000 
(Sp1)                S01187 + 503 8.117000 
EARLY-SEQ1           S01081 + 503 6.322000 
Sp1                  S00801 + 504 2.755000 
Sp1                  S00802 + 505 3.292000 
KROX24               S01623 - 508 5.378000 
Sp1                  S00781 - 509 2.772000 
Sp1                  S00978 - 510 3.361000 
Sp1                  S00326 - 511 9.386000 
Sp1                  S00979 - 511 6.023000 
AP-2                 S00180 + 513 1.863000 
 
Figure 4.2  
ROBO2 putative 
promoter predicted 
transcription factor 
binding sites and their 
binding probabilities    
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8451   ACAACCTTTCCAGTCCAAAAGGTGCTTCTATTTCCTTTCCTTTCCTTT CC 
8501   TTCCTCCTACTCGGCTTCTCATCTGGCTAAAAGGTGAAGAGTGAGTGAGT 
8551   GTGTGATTTTAACGCGTAATGAGGCTGCGCCCTGGGTCCTGGAGGCTGAT 
8601   CTTTTTCAAGAAAGCGCGTGCAGCTCCGGCAGACGGAGGGATGAATAATT 
8651   AGGAAGGGCTTCCATGAAATCACTCACGGAGAAAATTACCTGCCCATTAA 
8701   ACGGGACGCGGCGAGGAGCAGGAGCCTGGAGCCCACCTATCCCCTCCCGA 
8751   GGCGGGAAGGAGTGGGCACCCGGGGGCGCGGAGAAGGGGAAGGAGTCGCC 
8801   CGGTGGCCTCGGCCCTCGGCAGCCGGCGGGGCTCTCCGAATTTGTTCATC 
8851   TCCGTCCCCCCGGGGACTCTCGGCTCTCCAGGACCCCTCCCCACTCCCCA 
8901   GCGGGCGGGTGGCCGAGTCCGGAGGTTCAGGGCTCCGCGCGCCCCTCCTC 
8951   GCCCCCGCCCCTCCCCGGGCCGACTCCAGGCAGCTCTCATTCCTCCCCTC 
9001   CCCTCCCGCCTCCTCGCCTTCCCTCCTAGAAGTCCTTCCACCCGCGGCAG 
9051   CTGCCGGAGGAAGCGGACGCTCTGCTGCGAGGCTGCGGGGGCTGGACCCG 
9101   GGCGAGGGGCCTCAGCGCGCCTGGCGCTGGACTGAGCGCTCCCTTTCTCC 
9151   GCCGCGCCCGGGCTGGGCTCTCACGCCCGTCTCTGCTCGCGCCCGCAGCC 
9201   GCCTGGTGCACTATCCTCAGAGGCGGCACCGCGGGGGTGTCTGCAGCCTC 
9251   GGCCTCCGCCCGGCCCCTCCCTCCCTCCCTCCCTCCCTCGCTCCTTCCCT 
9301   GCCTCCCTCACCACGTAGGAGTTCGGATTCTCCACCCGAATCGTCCTGAT 
9351   TTCCCTTCTCCTCTCTTTTGGAAACCGGAGAGGTGGAGGGAGGGCAACAC 
9401   CGCTGCAAAGGAGAGGCCCGCCAAGTCTGCCCGCCTGCAAAGTGTTGCTT 
9451   TGACACATTCTTATTATGGAAGTTAAGTAAAAATATAGACATATTAAAAA 
9501   ATAACTCCGGACGTGGAGCTGCTACGGAGAAGGAAACCGGGGGAAAGAAA 
9551   ACCAGTAGGCAGGCCAATGGTTTTTCGGCAGCGCGCTGGCAAGTTTGTGG 
9601   AACACTTTCTAGGAATTAGGTCTTTTCCTCCCCCTTCATCATCTTGACTT 
9651   CTGAAGGAAGAACTTGGCTTTGGATTGCAGTGGAGCCTAAGGAGAGAGGG 
9701   TTAGACACACTCGAATAATCCCTCTGGCTGGGCTGAATTTGTGGGAATTT 
9751   AGGAAGCCAGAGTGCTGGAAATACAGCAGCCTTTGAAGTACCCTCTGTTA 
9801   ATTTGGATGGATCTCAGTGTGCCCCGTTCGAGACCTCTCCACCAACCCCT 
9851   TCTGATCTTGCGATTTGCTCTTCTTGACTTTAATTAGTATCTAGGAAAGT 
9901   CTAAACTTTGGACCTACCTCTTTTTTTGATACTCATTTTTGTACTTTTGC 
9951   TCTCTGGGATTGGTTTCTTAAAGAAT CTGGATCCTTTTTAATA TGTCAAA 
10001  “ATG” AGTCTGCTGATG TTTACACAACTACTGCTCT 
 
F1 
F2 
F3 
F4 
R2 Pro R5 
R2 Pro-R 
TSS 
Figure 4.3 Localization of ROBO2 primers in the putative promoter region that covers approximately -
1600bp downstream of ROBO2 TSS. TSS located at the 10000. Red Region is the putative CpG island 
and the Green region is the putative promoter. 
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4.1.3 Putative Promoter Site is Evolutionary Conserved  
As mentioned above a putative promoter sequence for ROBO2 was found with PromoterScan 
algorithm. It is located in the middle of a CpG island. It gives a high score for potential 
binding sites of transcription factors.  This sequence is validated by also other databases 
(GENOMATIX, CORG) and all returned with high scores for a potential promoter. This 
putative promoter region is compared with ClustalW algorithm for interspecies conservation 
analysis. -10kb region of Drosophila melanogaster, Mus musculus, and -2kb region of 
Human sequence were analyzed by ClustalW algorithm. 
 
 
Mus musculus and Human sequences showed strong similarities in the whole sequence 
where as Drosophila Melanogaster showed less similarity. However, in the CpG island and 
promoter regions all three species showed strong similarity. (Figure 4.6) This putative region 
does not contain a significant TATA box. It has got potential binding sites for AP2 (8 times), 
SP1 (9 sites), NF-kB, APRT, JCV, GCF, EGR-1, KROX24 (2 times).  
 
4.1.4 Identification of Putative CpG Islands of Other ROBO and SLIT Family Genes: 
SLIT1, SLIT3, and ROBO3 genes‟ upstream of TSSs were analyzed with Emboss CpG 
Plot. SLIT1 has two putative CpG islands one of them is between -56 and -321 and the other 
one is -352 and -575 bp relative to the TSS. ROBO3 has a CpG island located in -88 to -341. 
 
Figure 4.4:  Representative part from the CLUSTALW algorithm comparison of Human, Mus 
Musculus and Drosophila Robo2 upstream sequences 
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SLIT 3 has CpG Island located between -126 and -817. Primers for Methylation Specific PCR 
of SLIT 1, SLIT3 and ROBO3 were previously reported (Narayan G. et al., 2006). 
4.1.4 5-Aza-dC Treatment of HCC Cell Lines and Real Time PCR Analysis of ROBO- 
SLIT Family Genes in HCC Cell Lines: 
HCC cell lines with high AFP background (Hep3B, PLC, Focus, Huh7) and low AFP 
expressing cells (SkHep1, HepG2, Snu387, and Snu423) were treated with 5-Aza-dC at 
2.5µM concentration for 4 days. Total RNAs of these 5-Aza-dC treated and non treated cell 
lines were isolated and cDNA were prepared from these RNA. Real Time PCR analysis was 
performed with these cDNA to see that whether 5-Aza-dC treatment would have any effect on 
the expression patterns of ROBO-SLIT family members. Real Time PCR was performed in 
duplicates and transcript expression was normalized to GAPDH. Untreated cell lines were 
used as control.  
 
 
 
 
As shown in Figure 4.4, the expression of all analyzed genes (ROBO2, ROBO3, 
SLIT1, and SLIT3) increased in SkHep1 cell line, after 5-Aza-dC treatment. Snu387 showed 
an increase in SLIT1 and SLIT3. HUH7 showed definite increment in the SLIT3 and a slight 
increment in ROBO3.  In PLC SLIT3 was increased. Both HepG2 and Snu423 cell lines 
displayed an increment in SLIT1 expression and Focus showed an increase in ROBO2. The 
0
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SkHep1  
5 Aza  
Focus  5 
Aza   
Snu 387  
5 Aza 
Snu423  
5 Aza  
Huh7  5 
Aza    
PLC  5 
Aza     
HepG2  
5 Aza   
Hep3B   
5 Aza  
robo2
SLIT1
SLIT3
ROBO3
Figure 4.5 Real Time PCR Results of Expression patterns of ROBO1, ROBO2, ROBO3, SLIT1 and 
SLIT3 genes after 5-Aza-dC treatment of HCC cell lines. Results are in log2 based and non-treated 
results are all equal zero. Normalization was performed according to GAPDH.  
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Universal C. 
fact that SLIT-ROBO gene expression was rescued upon 5-Aza-dC treatment in HCC cell 
lines prompted us to study the methylation of their gene regulatory regions.  
4.1.5 Bisulfite Treatment of HCC Cell Lines and MS-PCR 
 
DNA of eight HCC cell lines (SKHep1, Focus, Snu387, Snu423, Huh7, PLC, HepG2, 
and Hep3B) was isolated and then subjected to bisulfite treatment. PCR reactions were run by 
using methylation-specific primers. Results were shown in Figure 4.5. 
 
 
 
 
 
 
 
 
 
Although ROBO2 had a hemi-methylated pattern of methylation generally, Focus, 
Snu423, PLC and HepG2 displayed stronger methylated bands than the unmethylated ones. 
Except Skhep1, all cell lines were found to be methylated for ROBO3. The methylation was 
more evident in cell lines with high-AFP background. SLIT1 shows a methylation pattern in 
the low-AFP HCC cell line group (SKHep1, Snu387, and Snu423) while it showed an 
unmethylated or hemi methylated pattern in the high-AFP HCC cell line group (Huh7, PLC, 
HepG2, Hep3B). No methylation of SLIT1 was observed in Huh7 cells. With regard to SLIT3 
analysis, low-AFP group cell lines displayed strong methylated bands and concomitantly  
present unmethylated bands, suggesting a hemi-methylated status of SLIT3 in these cells. 
However, the absence of unmethylated PCR product in PLC and barely detectable band in 
HUH7 indicated a stronger methylation of SLIT3 in cells with high-AFP expression.   
 
Figure 4.6: Methylation Specific PCR of ROBO2, ROBO3, SLIT1 and SLIT3 genes. M means 
methylated form specific primer U means unmethylated specific form primer. Right most band is 
the control for the bisulifte treatment. Completely methylated human DNA (from Zymo 
Epigenetics) was subjected to bisulfite treatment and checked for presence of methylation for 
bHMLH primers and gave positive result. 
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4.2 Cloning of ROBO2 Gene Regulatory Sequences (Promoter &Enhancer): 
 
4.2.1 Cloning of Different Fragments of Putative Promoter into pGL3 Luciferase 
Reporter Vector 
To characterize this promoter, we designed 4 different forward primers (F1, F2, F3, and 
F4) and one reverse primer. Forward primers are positioned just at the beginning of the CpG 
island (F1-ROBO2), beginning of the promoter sequence and neglecting the first part of CpG 
island (F2-ROBO2), at the end of the promoter region (F3-ROBO2), and at the end of the 
CpG island (F4-ROBO2) (Figure 4.3). Reverse primer is located just at the beginning of the 
transcription start site. Forward primers contain HindIII restriction site and reverse primer 
contains an NcoI restriction site for cloning into pGL3 luciferase reporter vector (Figure 4.7). 
NcoI restriction site is located just at the beginning of the luc coding region (Figure 4.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: pGL3-Basic Vector circle map. luc+, cDNA encoding the modified firefly luciferase; 
Ampr, gene conferring ampicillin resistance in E. coli; f1 ori, origin of replication derived from 
filamentous phage; ori, origin of replication in E. coli. Arrows within luc+ and the Ampr gene 
indicate the direction of transcription; the arrow in the f1 ori indicates the direction of ssDNA 
strand synthesis. (PROMEGA Corporation, Technical Manual for pGL3 luciferase reporter 
vectors. Manual Code :TM033) 
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By using these primer pairs, we amplified 1502 bp, 1378 bp, 986 bp, and 636 bp products 
corresponding to F1, F2, F3 and F4, respectively (Figure 4.9).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8:  Multiple cloning site of pGL3 basic vector. NcoI is located just at the beginning of the 
TSS of luc gene. R2-PRO R sits just at that site. Forward primers contain HindIII restriction site at 
their 5‟ end. (PROMEGA Corporation, Technical Manual for pGL3 luciferase reporter vectors. 
Manual Code : TM033) 
Figure 4.9: F1, F2, F3, and F4 inserts with sizes of 1502 bp, 1378 bp, 
986 bp, and 636 bp respectively. 
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The aforementioned fragments were cut with NcoI and HindIII for cloning and run in 
1% agarose gel. Cut inserts were isolated from the gel and ligated into the pGL3 vector. 
Plasmids were transformed into E.coli and Maxi Prep products were subjected to diagnostic 
restriction with the cloning enzymes (Figure 4.10). All products were at the right size. 
Vectors containing F1, F2, F3, and F4 inserts were named same as their inserts. F1, F2, F3, 
and F4 vectors were sequenced and no mutation was observed.  
 
 
 
 
 
 
 
 
 
 
 
4.2.2 Luciferase Assay for F1, F2, F3, F4 vectors 
Huh 7 cell line was selected for the transfection experiment since this cell line was 
previously shown to express ROBO2 gene and suitable for transfection. F1-F4 constructs, 
CMV promoter driven luciferase vector, renilla TK, empty pGL3, and a GFP vector were 
transfected to Huh7 cells. All transfections were made in triplicate. 48 hours after the 
transfection cells were collected and lysed for luciferase assay with Promega Dual Glo 
Luciferase Kit. GFP transfected wells were checked for transfection efficiency. Luciferase 
signals were normalized according to renilla signals. The mean of the triplicate samples were 
taken and divided to the empty vector (pGL3) transfection intensities. Results are shown in 
Figure 4.11. All of the constructs gave lower signal than the empty vector (pGL3). This 
might be due to either: 
 
 
Figure 4.10: Diagnostic restriction cut of F1, F2, F3, and F4 vectors with NcoI and 
HindIII. Left  band is the uncut pGL3 basic. 
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i. Since ROBO2 is a gene that functions in development it may need extra 
activating sequences (like an enhancer) additional to promoter. AND/OR, 
ii. Putative promoter of ROBO2 gene does not contain a TATA box and for this 
reason it is hard to provoke the sequence act as a promoter. AND/OR, 
iii. There is/are strong repressor binding sites in this region and therefore putative 
promoter could not act in full capacity. 
All of these possible reasons seem to act together and they all sourced from the 
functional nature of ROBO2 gene. As being a gene regulating developmental processes, it 
might be subjected to strict regulation and it needs a complex mechanism to be transcribed. 
At that time, Geisen MJ and colleagues showed that mouse Robo2 is a direct target of 
Hoxa2 (Geisen MJ. et al., 2008). Binding region of Hoxa2 was also shown as a putative 
enhancer for Robo2 gene by GENOMATIX database. This region covers 602 bp and located 
in intron1 (Figure 4.12). 2 sets of primers (Enhancer-Wide F/R & True Enhancer F/R) were 
designed for that region including the nested PCR primers. Primers contain SalI and BamHI 
restriction sites which are  
0
0.2
0.4
0.6
0.8
1
1.2
F1 F2 F3 F4 pGL3-basic
Figure 4.11: Luciferase assay results of F1, F2, F3, and F4 transfection. All transfections 
were made in triplicates. Non transfected wells‟ signals were accepted as background and 
subtracted from all of the results separately both for luciferase signals and renilla luciferase 
signals. Then luciferase signals were normalized according to renilla signals because renilla 
signals were the sign of transfection efficiency for each well. Then mean of the triplicate 
samples were taken and divided to the empty vector (pGL3-basic) transfection intensities. 
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present in the pGL3 basic vector just before the enhancer site of pGL3 enhancer vector. 
Putative enhancer region was amplified from the product of the nested PCR (Figure 4.13). 
To solve the TATA box problem a modified version of pGL3 vector (e1b-pGL3) was 
used which contains an e1b TATA box just before the XhoI restriction site in the multiple 
cloning site of the vector. New set of primers, which contain MluI and XhoI restriction sites, 
were designed for cloning the F1, F2, F3, and F4 regions after the e1b TATA box (F1 e1b, F2 
e1b, F3 e1b, and F4 e1b) (Figure 4.13).  
 
 
ACATAAAATTAAGTAAAAAAAAATGGGTAGATATCTCAAACACTTAAGAGAAGA CCATTG 
GAGAAAACCTCAAAAAATTGATAAATAAATAGTTTGCAACAATTAATAATGACAGTCTTT 
GTATTTAAGAAAAAAAATCAGGTAGACATCTTTCCATACATGAAGTTAAAATAAT CATGG 
GAATATTGAGTCCTTATCAA[ATCATAGCTTAAGTGGGAAAATCTAGGTAATACATATGTG 
TGAAAGTACACATTTTTTGGTTTTCTCTAGCATTCTTGAGGAATATTAATATTTGTTTTT 
TAAATGTTTTTATCCCTTTCAACTTTTAGTTTTCCCACTTTGAACCCTGATAATAGATTA 
TTGTAATCATTTTTAATCTCTCTTTTTCCTGTAGAATTCAGTGTTCTGATTTTTTATGAT 
AGGATCCACCTGATTTAGCTCAGGGATTCACTGAAAAATCAATTTAATATTTTTTTCCAA 
AGGTTGTATGGTCTTATGTGCAAACTGTAGCTATTCCTTTGTTCCAAAATATCTTATTTT 
ATTGAATGACATTGGATTCACAAGGCCTTATTAAAACACAGCTGAGGTACAGAGTTAGGT 
ACCTGTGTACCAAAAGTAAATTAGGTTTCCTTTGCTTTTTTCATAATGTACTTAAAGCAT 
GCATAATAGTTTATCTCATTTTACCATTGTTTCATTTTTTTTTTCAAGAACGACCCACAT 
TTCTCAGGAGGCCAATTAACCAGGTGGTACTGGAGGAAGAAGCTGTAGAATTTCGTTGTC 
AAGTCCAAGGAGATCCTCAACC]AACTGTGAGGTGGAAAAAGGATGATGCAGACTTGCCAA 
GAGGAAGG  TAAGACCAACATATGGATGGAAGATTGTTAGATAACCAATGAATAATTAGAA 
AATAAA  AGGACAGCTACAATGCCACCACC  AAACACTCCTATGTCTTGGGGTACTTTCACT 
 
Figure 4.12: Putative enhancer region of ROBO2 gene located in the first intron. Red region shows 
the enhancer. Green highlighted regions are True Enhancer F&R primers. Cyan highlighted ones are 
nested PCR primers Enhancer Wide F&R.  
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To explore whether putative promoter region contains repressor binding sites, we 
scanned for possible repressors with different TF binding site predictors. 7 possible (IRF8, 
Nf-1, Oct1, GR1-alpha, Pu.1, NKX2-5, YY1) transcriptional repressor binding sites were 
found in F4 region. To minimize the effects of these possible repressors F4 region was 
excluded from the F1, F2, and F3 regions by designing two new reverse primers. One was for 
pGL3 and the other one was for e1b-pGL3 vector and they were located just downstream of 
the F4–F3 intersection (Figure 4.2). New inserts were named as F1-F4, F2-F4, F3-F4 (Figure 
4.14), F1-F4 for e1b, F2-F4 for e1b, F3-F4 for e1b (Figure 4.14) and were synthesized from 
the nested PCR. 
Putative enhancer insert has been ligated to both pGL3 basic and pGL3-e1b vector 
successfully. The cloning of F4 omitted inserts into 4 different vectors (pGL3-basic, 
pGL3+enhancer, pGL3-e1b, pGL3-e1b+ enhancer) was envisaged in order to reveal the 
potential of the putative promoter region as the gene regulatory site of ROBO2 gene.  
a 
b Figure 4.13: (a) Putative 
enhancer region of ROBO2 
gene with 602 bp size.   
(b) Inserts F1, F2, F3, and 
F4 for e1b, which contain 
MluI and XhoI restriction 
sites at their ends. 
a 
b 
Figure 4.14: (a) F1-F4, F2-
F4, F3-F4 for e1b vector. 
(b)F1-F4, F2-F4, F3-F4 for 
pGL3 vector 
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5. DISCUSSION AND FUTURE PERSPECTIVES: 
Hepatocellular carcinoma is the fifth most common cancers worldwide and it is the 
third leading cause of cancer related deaths (Llovet JM. et al., 2003). Patients are often 
diagnosed at advanced stages of the disease when effective therapies are limited. In most 
cases, HCC develops on the basis of chronic hepatitis and cirrhosis, which in turn establish an 
environment of liver injury, inflammation and hepatocyte proliferation (Thorgeirsson SS and 
Grisham GW. et al., 2002). Therefore, understanding growth and survival pathways that 
influence hepatocarcinogenesis can reveal molecular components of this aggressive cancer 
and help to develop more efficient diagnostic and prognostic tools and novel therapeutic 
targets as well.  
Our group previously showed differential expression of SLIT-ROBO genes in HCC. 
(Avci ME et al. 2008). In the present study, we explored the epigenetic regulation of this 
family of genes in eight HCC cell lines, with a special focus on their methylation pattern. 
ROBO1 was previously shown to be overexpressed in HCC (Ito H., et al., 2006). More 
recently, SLIT2 inactivation in liver cancer by hypermethylation was also defined (Jin J. et al., 
2009). On the other hand, several reports indicated vascular endothelium limited expression 
of ROBO4. Hence, we limited our methylation analyses to SLIT1, SLIT3, ROBO2 and ROBO3 
genes whose methylation was never studied in HCC.  
Initially, we treated cell lines by 5-Aza-dC to assess whether transcription of SLIT-
ROBO genes can be rescued. However, we obtained only partial gene expression response of 
cell lines under our treatment conditions. For instance, we treated SkHep1 cells with 2.5 µM  
for 2 days and 4 days and also with 5µM for the same time scale. Then we evaluated the 
expression of ROBO3 by Real Time PCR and observed that cells treated with 2.5 µM of 5-
Aza-dC for 4 days displayed increased ROBO3 expression. In fact, lower doses of drug 
treatment was safer than higher doses, since drug concentrations beyond 5 µM appeared to be 
toxic and led to cell death. However, some groups treated cells with 10 µM for 10 days (Fan 
H. et al., 1996), and accordingly, our dose could not be enough to relieve all the methylation 
in the genome. Nevertheless, this partial response led us to study the hypermethylation of 
aforementioned SLIT-ROBO genes.  
Unlike partial response that cells displayed under our treatment conditions, all HCC 
cell lines were shown to have methylated SLIT-ROBO genes with a few exceptions. The most 
striking methylation pattern was observed in ROBO3 gene, which was heavily methylated in 
all cell lines except SkHep1. This latter displayed hemi-methylation, yet in Real-Time PCR 
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analysis, 5-Aza-dC treated cells showed a 4.6 fold increase in ROBO3 expression when 
compared to untreated cells. Also Huh7 cell displayed a slight increase near to 2 fold. In other 
cell lines treated with 5-Aza-dC, no ROBO3 amplification was observed with three different 
sets of primers. This was most likely due to low dose treatment conditions, but also indicated 
that ROBO3 gene regulatory region is heavily methylated. Cell lines that were selected for 
methylation analysis also cover the high-AFP expressing well differentiated and low-AFP 
expressing poorly differentiated stages of HCC. Therefore, fully methylated pattern of 
ROBO3 in all cell lines suggests that the inactivation of ROBO3 is an early event in 
hepatocarcinogenesis. It was recently shown that ROBO3 represses ROBO1, which was also 
shown to be overexpressed in HCC (Sabatier C. et al., 2004).  Our results are in accordance 
with this finding and implicate a possible role of ROBO1-ROBO3 axis in HCC development. 
There are only few studies describing ROBO3 methylation in human cancers. One report 
demonstrated the inactivation of ROBO3 by hypermethylation in cervical cancer (Narayan G 
et al. 2006). However, in the same study ROBO1 promoter region was also shown to be 
methylated. Thus, opposite behavior of ROBO1 and ROBO3 appears to occur only in liver 
cancer and it is worthy to examine ROBO3 role as a potential tumor suppressor gene in HCC 
Both methylation and hemi-methylation of SLIT1 were observed. Also low-AFP 
expressing SkHep1, Focus, Snu387, and Snu423 had got stronger methylation pattern than the 
high-AFP expressing PLC, HepG2, Hep3B and Huh7. These results were in accordance with 
our previous findings that SLIT1 expression was more obvious in HCC cell lines with high-
AFP background (Avci ME et al. 2008). In this previous observation, SLIT3 expression was 
found to be confined to low-AFP group of cell lines. The methylation analysis confirmed this 
pattern of gene expression in that high-AFP cells had barely detectable unmethylated DNA 
amplification.  
ROBO2 had a hemimethylated pattern in HCC cell lines, yet this was more obvious in 
high-AFP expressing cells. In other words, low-AFP group of cells displayed heavier 
methylation. This finding validates our previous results showing ROBO2 expression in HCC 
cell lines of high-AFP group. To our best knowledge, ROBO2 methylation was only studied 
in head and neck squamous carcinoma (Ghosh S. et al., 2009). The limited data on epigenetic 
regulation of ROBO2 is most probably due to the lack of knowledge about its gene regulatory 
sequence. Hence, this study also targeted to identify the promoter of ROBO2 gene given that 
our methylation specific primers were designed from the CpG island that covers the putative 
promoter sequence. 
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Since MS-PCRs were performed in 45 cycles, it was a high probability that the 
reactions have reached the saturation plateau. For this reason quantitative analysis should be 
performed in order to establish a reliable connection between the expression pattern panel and 
MS-PCR. Also there may be transcriptional regulation mechanisms other than CpG 
methylation that have a role in the regulation of these genes. So it is hard to say that there is 
100% correlation between the MS-PCR and expression panel but it is obvious that there is a 
strong relation between these two.      
Promoter prediction analysis of ROBO2 initially gave high prediction score and high 
transcription factor binding probabilities. The potential of this region as a gene regulatory site 
was also validated by the presence of a CpG island that covers the putative promoter region. 
Several fragments corresponding to this region were cloned into pGL3-basic luciferase vector. 
However our initial experiments failed to work because of the inherent features of this 
putative promoter. Since ROBO2 takes role in the developmental processes, it might have 
complex transcriptional control mechanisms than the other genes that are controlled basically 
on their close proximity promoter. Lack of a TATA box in the close proximity of the TSS 
supports that hypothesis. The absence of a TATA box led us to clone promoter fragments into 
TATA box containing reporter vector along with an enhancer, which is located in the first 
intron of ROBO2. Furthermore, analysis of the F4 promoter fragment also revealed a potential 
repressor binding site. Therefore we also envisaged to omit this region from previously cloned 
fragments.  
 Herein, we described the methylation of SLIT-ROBO genes in hepatocellular 
carcinoma cell lines and found out that this pathway is regulated in this cancer. Fully 
methylated pattern of ROBO3 gene might give insight into the identification of a new 
pathway in liver cancer, taken together with the overexpression of ROBO1, which is confined 
to HCC.  
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Future Perspectives: 
Planned future works are as follows: 
 
(i) Extending methylation studies to HCC patients in order to explore whether our 
cell line data translate into in vivo conditions. 
(ii) Functional studies with ROBO3 gene that will deal with the transfection of 
ROBO3 into HCC cell lines and assess their phenotype thereof.  
(iii) To design new reporter assays that will take into account the inherent 
properties of ROBO2 gene regulatory sequence. 
(iv) TSA treatment additional to 5-Aza-dC treatment may help to relieve the 
epigenetic pressure, especially on ROBO3 gene.  
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CHAPTER 6 APPENDICES 
Appendix A Sequencing Results of  F1, F2, F3, F4 Constructs 
 
F1 Sequencing with RV3 primer which scans the first 500 bp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F1 Sequencing with GL2 Primer scans the region that resides between F4 and F3 
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F1 sequencing with F4 primer which scans the last 600 bp of F1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
